Quris AI logo

Quris AI

Leading the AI-Pharma Revolution

35 employees · est. 2019 · Boston, United States

VS
Sable Bio logo

Sable Bio

Empowering Discovery: Precision Insights for Safer Drug Targets.

16 employees · est. 2023 · London, United Kingdom

Quris AI is the older company (2019 vs 2023).

Side-by-Side Comparison

Quris AI Sable Bio
Founded
2019 older 2023
Headquarters
Boston, United States London, United Kingdom
Employees
35 16
Industry
AI, Biotechnology, Health Care AI, Biotechnology, Pharmaceutical
Funding Stage
Seed Seed
Total Funding
$37.00M $4.24M
Funding Rounds
3 2
Services
AI-driven drug safety platforms, Machine Learning model training, Testing drugs with Patients-on-a-Chip technology, Reducing clinical trial failures AI-driven toxicology analysis platform, Unified safety data management, Risk prioritization and mitigation
Target Customers
Pharmaceutical companies, Biotechnology firms, Clinical researchers, Healthcare institutions toxicologists, pharmaceutical companies, biotech firms, safety teams
Taxonomy
AI-Pharma, Drug Development, Bio-Platform, Clinical Safety Prediction, Efficacy Prediction, Clinical Testing, Automated AI Platform, Cost-effective Drug Development, Minimizing Animal Testing, Failed Clinical Trial Reduction, AI-Based Drug Drug Safety Prediction, Clinical Side Effects Assessment, Drug Development Optimization, Data-Driven Drug Development, AI In Biomedical Data Analysis, Target Safety Insights, Assay Validation Strategies, Risk Minimization In Drug Development, Toxicity Testing, Biopharmaceutical Data Solutions, Advanced Workflows, Healthcare Data Analytics, Biomedical Data Insights, Pharmaceutical Validation
Website
quris.ai sablebio.com
Quris AI logo

About Quris AI

Quris AI, founded in 2019, is at the forefront of the AI-Pharma Revolution with its cutting-edge artificial intelligence technologies aimed at reshaping drug development. The company, headquartered in the United States, is making waves in the AI, Biotechnology, Health Care, Pharmaceutical, and Robot...

Sable Bio logo

About Sable Bio

Sable Bio, founded in 2023, is a UK-based innovator at the nexus of AI, Biotechnology, and Privacy and Security. The company is committed to transforming drug development with its pioneering approach to predicting drug safety, thereby minimizing trial failures and optimizing patient outcomes. Their...

We will tell you when either one moves

BounceWatch watches Quris AI and Sable Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Quris AI and Sable Bio — by email.

Frequently Asked Questions

Quris AI — Leading the AI-Pharma Revolution. Sable Bio — Empowering Discovery: Precision Insights for Safer Drug Targets.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Quris AI has raised $37.00M while Sable Bio has raised $4.24M.
Quris AI and Sable Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Quris AI with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Quris AI on 15 Jun 2026, and Sable Bio on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy